Xianzhengda partners with Amoéba to develop amoeba-based biocides for the EU and UK markets

Published 2025년 11월 19일

Tridge summary

Core tip: According to a report from the World Agrochemical Network Chinese website: Acanthamoeba is a type of single-celled microorganism that can help wheat and other cereal crops resist devastating fungal diseases. These diseases cause billions of dollars in crop losses annually worldwide and reduce crop quality. According to Syngenta, the bio-fungicide developed from the lysate of Acanthamoeba (Willaertia magna C2c Maky) has great potential in biological control. In trials, the product demonstrated effectiveness against pathogenic fungi and can activate the plant's defense mechanisms. As a new generation of biological agents, it is developed based on bioactive substances and is specifically designed to fit modern integrated crop management programs.

Original content

Syngenta and French green technology innovation company Amoéba have signed a memorandum of understanding to jointly develop and commercialize breakthrough biocontrol solutions for the European Union and the UK markets, focusing on field crops such as cereals. The two parties plan to reach a final distribution agreement in spring 2026. This strategic partnership aims to provide farmers with advanced biocontrol solutions to enhance the sustainability of agricultural practices, address the growing problem of pesticide resistance, and the challenge of the continuous reduction of plant protection products available to farmers. In the initial phase of the cooperation, the focus will be on controlling the main wheat diseases, namely leaf blight and stripe rust. These two diseases cause the most severe economic losses in the European and UK regions, affecting approximately 9 to 12 million hectares of wheat annually. According to authoritative industry and academic sources, in Germany ...
Source: Foodmate

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.